Table 1.

Patients with similar baseline and clinical characteristics were selected from the group managed within 24 h and matched with those managed 25-72 h

Case number	Gender		Age/yrs		ASA		BMI		Severity grade		APACHE II score
	≤24 h	25- 72 h	≤24 h	25- 72 h	≤24 h	25- 72 h	≤24 h	25- 72 h	≤24 h	25- 72 h	≤24 h	25- 72 h
1	M	M	69	68	2	2	32.4	23.8	1	1	5	7
2	M	M	74	74	3	3	35.2	26.1	2	3	9	7
3	F	F	69	70	3	3	32.4	35.8	2	2	8	6
4	M	M	82	84	4	3	28.7	27.4	3	3	18	17
5	F	F	30	22	2	2	25.5	25.4	2	2	1	1
6	F	F	68	61	1	2	26.2	41.5	2	2	6	5
7	F	F	39	39	2	2	32.3	24.8	1	1	2	1
8	M	M	76	74	4	4	34.9	33.1	3	3	18	19
9	M	M	74	74	3	4	25.1	26.8	2	3	17	18
10	M	M	80	76	2	2	28.4	23.6	2	1	14	13
11	F	F	46	45	2	1	38.6	28.7	1	1	3	2
12	M	M	42	43	2	2	28.1	27.0	1	1	2	2
13	F	F	37	37	2	1	26.3	29.7	1	1	1	1
14	F	F	60	55	2	2	32.8	31.0	1	1	4	4
15	F	F	84	81	2	1	25.4	20.8	2	1	11	14
16	M	M	76	71	3	3	31.6	25.6	1	1	11	11
17	M	M	57	60	2	2	29.6	29.0	1	1	5	8
18	F	F	45	47	2	2	31.3	33.2	1	1	3	2
19	M	M	34	31	1	1	26.2	17.0	1	1	1	1
20	F	F	43	42	3	3	29.4	26.6	1	1	2	3
21	F	F	76	71	3	3	27.2	31.6	2	1	9	6
22	M	M	56	56	2	1	24.2	24.7	1	1	6	6
23	M	M	43	45	1	2	24.2	22.0	1	1	1	2
24	M	M	80	79	3	3	16.2	19.4	1	2	9	9
25	F	F	51	54	2	2	24.8	24.4	1	1	4	3
26	M	M	52	59	2	2	28.7	26.2	1	1	4	4
27	M	M	73	74	2	2	30.8	29.2	2	1	8	5
28	F	F	61	65	3	3	26.0	33.5	3	3	15	13
29	F	F	82	83	3	3	31.2	21.5	1	1	7	5
30	M	M	65	61	2	1	25.7	26.5	1	1	8	5
31	M	M	64	63	2	2	25.1	21.6	1	2	9	7
32	M	M	79	77	3	3	33.9	31.2	3	3	13	11
33	M	M	82	87	3	3	29.9	27.6	2	3	19	18
34	M	M	71	76	2	2	30.2	33.8	1	1	11	11
35	F	F	68	63	2	1	30.2	34.1	1	1	11	11

Both groups were comparable in terms of demographic and clinical parameters.